| |
| |
|
| Insider
Information: |
Gross Phillip |
| Relationship: |
10% Owner |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
26 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
133,228,723 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$3,815,619,731 |
|
|
| Total
Shares |
133,228,723 |
|
|
| Total
Value |
$3,815,619,731 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
24
|
66
|
|
Stock
price went up :
|
8
|
10
|
| Stock
price went down : |
16
|
56
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -3.8%
|
-765.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boulder Brands Inc |
BDBD |
10% Owner |
2007-09-07 |
0 |
2013-02-01 |
5,939,492 |
Premium* |
|
|
Hubbell Inc |
HUBB |
10% Owner |
|
0 |
2008-04-25 |
727,000 |
Premium* |
|
|
Pacific Sunwear Of California Inc |
PSUN |
10% Owner |
2008-07-11 |
0 |
2016-04-06 |
5,127,926 |
Premium* |
|
|
Sleep Number Corp |
SCSS |
See Remarks. |
|
0 |
2011-02-09 |
5,415,000 |
Premium* |
|
|
Celanese Corp |
CE |
10% Owner |
|
0 |
2009-02-02 |
13,588,774 |
Premium* |
|
|
AMAG Pharmaceuticals Inc |
AMAG |
10% Owner |
2009-03-04 |
0 |
2015-01-09 |
2,546,592 |
Premium* |
|
|
Correvio Pharma Corporation |
CORV |
10% Owner |
2009-04-09 |
0 |
2010-04-14 |
6,700,000 |
Premium* |
|
|
Mandalay Digital Group Inc |
MNDL |
10% Owner |
|
0 |
2012-03-01 |
10,053,333 |
Premium* |
|
|
Puma Biotechnology Inc |
PBYI |
10% Owner |
2012-04-26 |
0 |
2017-06-12 |
3,696,580 |
Premium* |
|
|
Concert Pharmaceuticals, Inc. |
CNCE |
10% Owner |
|
0 |
2014-02-20 |
510,147 |
Premium* |
|
|
HeartWare International Inc |
HTWR |
10% Owner |
|
0 |
2015-08-03 |
1,722,969 |
Premium* |
|
|
Calithera Biosciences, Inc. |
CALA |
10% Owner |
|
0 |
2017-09-28 |
3,546,873 |
Premium* |
|
|
Advaxis Inc |
ADXS |
10% Owner |
|
0 |
2017-10-11 |
4,100,043 |
Premium* |
|
|
Nexvet Biopharma Plc |
NVET |
10% Owner |
2014-02-10 |
0 |
2014-02-10 |
875,000 |
Premium* |
|
|
Five Prime Therapeutics Inc |
FPRX |
10% Owner |
|
0 |
2015-10-15 |
2,539,949 |
Premium* |
|
|
Vitae Pharmaceuticals, Inc |
VTAE |
10% Owner |
|
0 |
2016-09-14 |
2,375,000 |
Premium* |
|
|
Mulesoft, Inc |
MULE |
10% Owner |
2017-03-17 |
0 |
2017-03-17 |
675,000 |
Premium* |
|
|
Solaris Oilfield Infrastructure,... |
SOI |
10% Owner |
2017-05-12 |
0 |
2017-05-12 |
1,275,000 |
Premium* |
|
|
Protagonist Therapeutics, Inc |
PTGX |
10% Owner |
|
0 |
2017-05-30 |
2,056,076 |
Premium* |
|
|
Orbcomm Inc. |
ORBC |
10% Owner |
|
0 |
2020-08-12 |
7,697,220 |
Premium* |
|
|
Royalty Pharma Plc |
RPRX |
10% Owner |
2020-06-18 |
0 |
2020-12-18 |
38,714,280 |
Premium* |
|
|
Advent Technologies Holdings Ord... |
ADN |
10% Owner |
|
0 |
2020-12-03 |
781,535 |
Premium* |
|
|
Gcm Grosvenor Inc. |
GCMG |
10% Owner |
2021-05-18 |
0 |
2023-05-10 |
4,158,641 |
Premium* |
|
|
Abacus Life Ord Shs Class A |
ABL |
10% Owner |
|
0 |
2023-01-23 |
0 |
Premium* |
|
|
Abeona Therapeutics Inc |
ABEO |
10% Owner |
|
0 |
2023-07-03 |
3,249,994 |
Premium* |
|
|
EyePoint Pharmaceuticals Inc |
EYPT |
10% Owner |
|
0 |
2024-04-18 |
5,156,299 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
293 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMAG |
AMAG Pharmaceuticals Inc |
10% Owner |
– – • |
2013-09-05 |
4 |
D |
$24.98 |
$117,406 |
I/I |
(4,700) |
3,816,592 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
10% Owner |
– – • |
2013-09-04 |
4 |
D |
$24.90 |
$94,620 |
I/I |
(3,800) |
3,821,292 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
10% Owner |
– – • |
2013-09-03 |
4 |
D |
$24.50 |
$245,000 |
I/I |
(10,000) |
3,825,092 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
10% Owner |
– – • |
2013-08-30 |
4 |
D |
$23.70 |
$440,820 |
I/I |
(18,600) |
3,835,092 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
10% Owner |
– – • |
2017-06-08 |
4 |
S |
$81.49 |
$852,588 |
I/I |
(10,462) |
3,843,840 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
10% Owner |
– – • |
2013-08-29 |
4 |
D |
$24.76 |
$247,600 |
I/I |
(10,000) |
3,853,692 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
10% Owner |
– – • |
2017-06-08 |
4 |
S |
$80.88 |
$7,242,021 |
I/I |
(89,538) |
3,854,302 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
10% Owner |
– – • |
2013-08-26 |
4 |
D |
$25.00 |
$77,500 |
I/I |
(3,100) |
3,875,692 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
10% Owner |
– – • |
2013-08-21 |
4 |
D |
$23.46 |
$9,384 |
I/I |
(400) |
3,903,792 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
10% Owner |
– – • |
2013-08-06 |
4 |
|
$23.50 |
$25,850 |
I/I |
1,100 |
3,904,192 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
10% Owner |
– – • |
2013-08-02 |
4 |
D |
$23.70 |
$344,428 |
I/I |
(14,500) |
3,905,292 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
10% Owner |
– – • |
2013-08-01 |
4 |
D |
$23.00 |
$1,633,418 |
I/I |
(70,538) |
3,919,792 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
10% Owner |
– – • |
2017-06-05 |
4 |
S |
$85.32 |
$28,037,032 |
I/I |
(307,128) |
3,943,840 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
10% Owner |
– – • |
2012-07-16 |
4 |
B |
$11.21 |
$1,715,130 |
I/I |
153,000 |
3,967,119 |
1.5 |
- |
|
| PBYI |
Puma Biotechnology Inc |
10% Owner |
– – • |
2012-07-25 |
4 |
B |
$12.00 |
$1,848,000 |
I/I |
154,000 |
3,982,519 |
1.5 |
- |
|
| PBYI |
Puma Biotechnology Inc |
10% Owner |
– – • |
2012-07-25 |
4/A |
B |
$12.00 |
$184,800 |
I/I |
15,400 |
3,982,519 |
1.5 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
10% Owner |
– – • |
2013-07-31 |
4 |
D |
$23.00 |
$2,185,000 |
I/I |
(95,000) |
3,990,330 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
10% Owner |
– – • |
2013-05-22 |
4 |
D |
$24.00 |
$1,200,000 |
I/I |
(50,000) |
4,085,330 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
10% Owner |
– – • |
2012-03-01 |
4 |
B |
$15.55 |
$5,666,218 |
I/I |
364,387 |
4,088,296 |
1.5 |
- |
|
| ADXS |
Advaxis Inc |
10% Owner |
– – • |
2017-10-11 |
4 |
S |
$4.30 |
$2,580,000 |
I/I |
(600,000) |
4,100,043 |
0 |
- |
|
| CALA |
Calithera Biosciences, In... |
10% Owner |
– – • |
2017-03-22 |
4 |
B |
$10.25 |
$4,999,991 |
I/I |
487,804 |
4,122,873 |
1.5 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
10% Owner |
– – • |
2012-03-02 |
4 |
B |
$15.97 |
$751,133 |
I/I |
47,034 |
4,135,330 |
1.5 |
- |
|
| GCMG |
Gcm Grosvenor Inc. |
10% Owner |
– – • |
2023-05-10 |
4 |
S |
$7.34 |
$849,114 |
I/I |
(115,578) |
4,158,641 |
0 |
% |
|
| PBYI |
Puma Biotechnology Inc |
10% Owner |
– – • |
2017-06-02 |
4 |
S |
$83.06 |
$2,531,287 |
I/I |
(30,475) |
4,250,968 |
0 |
- |
|
| GCMG |
Gcm Grosvenor Inc. |
10% Owner |
– – • |
2023-05-09 |
4 |
S |
$7.69 |
$335,260 |
I/I |
(43,560) |
4,274,489 |
0 |
% |
|
293 Records found
|
|
Page 5 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
